Revolutionizing

women's health

Empowering patients and healthcare professionals with intelligent drug delivery and health data.

Introducing the first personalized vaginal drug delivery device

The LiGalli MedRing

The LiGalli MedRing supports drug administration as desired. The right dose at the right time, up to 28 days.

The vagina provides an excellent environment for drug intake and monitoring of bio signals.

While the device is in use, a programmable schedule takes care of the drug delivery, without the need for the user to remember – improving therapy compliance. 

LEARN MORE

The MedRing Platform

Device

MedRing

Designed to deliver drugs systemically via the vaginal wall and monitor bio signals.

Suitable for a range of drugs.

Smartphone

Companion App

Enable patients to schedule and monitor drug administration within predefined boundaries.

Cloud

Data Platform

Enables secure storage of collected health data and, with consent, share it with healthcare professionals.

LiGalli is founded by a dedicated team of professionals with deep expertise in women’s health and medical devices.

We believe treatment for women requires significant improvement.
Our aim is to develop solutions that are
more precisely tailored to the unique needs of women.

At LiGalli we collaborate with the best-in-class industry experts,
ensuring that innovation is driven by both scientific excellence
and deep understanding of women’s health.

About
LiGalli

Meet the team >>

Our Partners

Edit Template

Get in touch

Office
Leiden Bio Science Park – BioPartner 1

Address
J.H. Oortweg 21
2333 CH Leiden
The Netherlands

Menu

Home
Product
Science
Company
News
Contact
Edit Template
Disclaimer policy
Privacy & Cookies
Edit Template